SPONSOR
Weijia Fang, MD
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Colorectal CancerSolid CancersGastric CancerMetastatic TumorAdvanced Solid TumorRenal Cell CarcinomaOvarian CancerCervix CancerStomach CancerPancreatic Cancer
Weijia Fang, MD is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Colorectal Cancer, Solid Cancers, Gastric Cancer, Metastatic Tumor.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Weijia Fang, MD
How many clinical trials has Weijia Fang, MD sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Weijia Fang, MD, of which 3 are actively recruiting participants. These trials cover conditions including Colorectal Cancer, Solid Cancers, Gastric Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Weijia Fang, MD research focus on?
Weijia Fang, MD clinical trials span Colorectal Cancer, Solid Cancers, Gastric Cancer, Metastatic Tumor, Advanced Solid Tumor, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Weijia Fang, MD clinical trial?
To participate in a Weijia Fang, MD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Weijia Fang, MD trials with current recruitment status updated daily.
Clinical Trials by Weijia Fang, MD
NCT05396300 Phase 1
Recruiting
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Colorectal Cancer
NCT05518253 Phase 1
Recruiting
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Metastatic Tumor
NCT06821048 Phase 1
Recruiting
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
Colorectal Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology